Skip to content Skip to footer
THE PROBLEM

FAST RECOGNITION

If any of this sounds familiar, you’re in the right place.

AI designs iterate faster than the lab
Expression fails late, after weeks of work
Complex proteins don’t fold in cells
Toxic proteins kill their host cells
Switching between bacterial and mammalian systems adds cost and variability
TWO WAYS OF SPEED

ALiCE® FITS
YOUR WORKFLOW

Whether you need protein fast or want to build internal capability.

I Need Answers Fast

Get expression data and protein without infrastructure.

I Need This Capability In-House

Run ALiCE® internally and compress your design-build-test cycles.

UNIQUE DIFFERENTIATOR

FULL-LENGTH MEMBRANE PROTEINS

Not fragments. The real target.

Most membrane protein workflows do not produce full-length proteins. They produce fragments or rely on post-expression insertion into artificial systems. These shortcuts often compromise folding, structure, and function — creating problems that appear later in development.

ALiCE® is different.

Proteins are inserted directly into native membranes during expression through an active biological translocation pathway. This allows full-length membrane proteins to fold, orient, and assemble correctly from the start.

PROOF OF CONCEPT

AENEAN LEO LIGULA PORTTITOR EU PROOF OF CONCEPT

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu

Market Segments

FIND WHERE ALiCE® FITS YOUR WORKFLOW

ALiCE® supports teams across discovery and development, from early research to platform-scale operations. Each use case answers one simple question: Can faster, earlier expression data improve your decisions. Explore how ALiCE® supports:

  • Large Pharma
  • Biotech
  • CROs and CDMOs
  • AI Protein DesignVaccines and CGT
  • Agriculture and Food
Bild1
Technology

HOW ALiCE®
WORKS

ALiCE is a plant-based, cell-free protein expression system. Instead of relying on living cells, it uses a controlled biochemical environment that removes viability constraints.

This enables rapid expression, compatibility with difficult proteins, and direct integration into automated workflows.

Because the system is open and engineerable, it supports novel protein formats, non-canonical amino acids, and membrane protein insertion.

COMPARIONS

WHY TEAMS
SWITCH TO ALiCE®

Traditional expression systems were designed for stability, not speed. HEK, CHO, and CRO workflows require cloning, cell culture, and optimization cycles before expression is confirmed. ALiCE® removes these delays. Expression begins immediately from DNA, and results arrive while decisions are still inexpensive. If speed, flexibility, and early risk reduction matter, ALiCE® provides a clear advantage.

Bild2

KNOW WHAT YOU GET BEFORE YOU COMMIT

ALiCE® screening provides clear, structured expression data and optional protein output. Pricing is based on screening scale and format, allowing teams to start small and expand as needed. No hidden optimization cycles. No unexpected delays.

Just answers.

ALiCE® IS NOT FOR EVERYONE

If your protein expresses reliably and timelines are not critical, traditional systems may be sufficient. ALiCE® delivers the greatest value when speed, complexity, or uncertainty are limiting progress.

That focus is intentional.

START YOUR SCREENING

FIVE MINUTES NOW CAN SAVE MONTHS LATER

Screen your protein with ALiCE® and get expression data while decisions are still flexible. Full-length proteins. Native membranes. Rapid answers.

Go to Top
Our site uses cookies. Learn more about our use of cookies: Privacy Policy

PEGS Boston – Protein & Antibody Engineering Summit | May 11 – 15, 2026